Literature DB >> 31407256

Osteosclerotic myeloma without features of POEMS syndrome.

Toshiki Terao1, Kosei Matsue2.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31407256     DOI： 10.1007/s12185-019-02718-7

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  3 in total

1.  Increased bone mineral density in a subset of patients with relapsed multiple myeloma who received the combination of bortezomib, dexamethasone and zoledronic acid.

Authors:  E Terpos; D Christoulas; P Kokkoris; K Anargyrou; M Gavriatopoulou; M Migkou; K Tsionos; M A Dimopoulos
Journal:  Ann Oncol       Date:  2010-05-23       Impact factor: 32.976

2.  Dramatic response of diffuse osteosclerosis secondary to multiple myeloma using thalidomide with melphalan and prednisolone.

Authors:  Muhajir Mohamed; Terry Brain; Alhossain Khalafallah
Journal:  J Clin Oncol       Date:  2014-02-10       Impact factor: 44.544

Review 3.  Multiple myeloma associated with diffuse osteosclerotic bone lesions: a clinical entity distinct from osteosclerotic myeloma (POEMS syndrome).

Authors:  M Q Lacy; M A Gertz; C A Hanson; D J Inwards; R A Kyle
Journal:  Am J Hematol       Date:  1997-12       Impact factor: 10.047
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.